UCLA scientists use ultrasound to jump-start a man’s brain after coma
New noninvasive technique may lead to low-cost therapy for patients with severe brain injury
2016 “Enhancing Student Success in Science” Workshop
In March, UCLA’s Divisions of Life and Physical Sciences sponsored a two-day workshop/retreat to familiarize key faculty leaders with the
UCLA professor Stephen Hubbell wins International Prize for Biology
Stephen Hubbell, a distinguished professor of ecology and evolutionary biology at UCLA, is the 2016 laureate of the International Prize for Biology for his outstanding contributions to biology research, Japan’s Society for the Promotion of Science announced Friday. The International Prize for Biology as one of the highest scientific honors bestowed by Japan.
Preventing mass extinctions of big mammals will require immediate action
UCLA professor, Blaire Van Valkenburgh, and her co-authors warn that steps must be taken now if gorillas, rhinos, lions and tigers are to be saved
Analysis of metastatic prostate cancers suggests treatment options
A collaborative study, between UC Santa Cruz and UCLA, maps out abnormal signaling pathways in prostate cancer cells and provides computational approaches to identify individualized targets for therapy
UCLA hosts summer program for future biosciences leaders
Twenty-eight outstanding undergraduates from across the country are spending eight weeks at UCLA this summer, conducting research and learning the latest data analysis techniques and skills that are transforming the biosciences.
Should the gray wolf keep its endangered species protection?
New genomic research by UCLA biologists provides a scientific answer
Literature and film help teach students to understand the brain
Scott Chandler, professor of Integrative Biology and Physiology, teaches an innovative interdisciplinary course combining anatomy, history, philosophy and humanities to teach neuroscience
UCLA Duchenne muscular dystrophy research receives grant from California’s stem cell agency
UCLA life scientist April Pyle– and colleagues Melissa Spencer and Huan Meng– received $2.15 million from the California Institute for Regenerative Medicine to develop a stem cell gene editing technology called CRISPR/Cas9 to correct the genetic mutations that cause Duchenne.